Intel's Q2 Should Be A Game Changer (Earnings Preview)

An analyst maintains a Buy rating on Intel (INTC), forecasting a strong Q2 earnings beat driven by exceptionally low consensus estimates and effective strategic pivots under new CEO Lip-Bu Tan. This positions INTC as a compelling contrarian opportunity, with potential for significant upward repricing as the market currently undervalues its ongoing turnaround despite acknowledged execution risks.

Analysis

The investment thesis for Intel (INTC) is presented as a compelling contrarian opportunity, centered on the expectation of a strong Q2 earnings beat. This forecast is underpinned by the view that current consensus EPS estimates establish an unusually low performance bar, which appears misaligned with management's guidance for relatively stable sequential results, thereby increasing the probability of a positive surprise. Further bolstering this bullish outlook are the strategic actions initiated by the new CEO, Lip-Bu Tan, including decisive cost-cutting measures and a pivot to refocus the foundry business. These moves are interpreted as signals of a pragmatic and aggressive turnaround strategy. While the analysis explicitly acknowledges that execution risks remain high, it positions the stock as a speculative play where an earnings catalyst could lead to a significant upward repricing due to perceived market underestimation of the turnaround's potential.

Key Decisions for Investors

• Investors with a higher risk tolerance could consider a long position based on the contrarian view that a low-bar for Q2 earnings creates a favorable setup for a stock-moving beat.
• The upcoming Q2 earnings announcement and management's commentary on the foundry business and cost-cutting progress are critical catalysts to monitor, as they will validate or challenge the turnaround thesis.
• Given the acknowledged high execution risks, investors should consider the speculative nature of this position and be prepared for volatility if the company's strategic pivots fail to yield positive results.